The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Specific deletion of Na V 1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome
Open accessAbstract
Heterozygous loss-of-function mutations in the brain sodium channel Na V 1.1 cause Dravet syndrome (DS), a pharmacoresistant infantile-onset epilepsy syndrome with comorbidities of cognitive impairment and premature death. Previous studies using a mouse model of DS revealed reduced sodium currents and impaired excitability in GABAergic interneurons in the hippocampus, leading to the hypothesis that impaired excitability of GABAergic inhibitory neurons is the cause of epilepsy and premature death in DS. However, other classes of GABAergic interneurons are less impaired, so the direct cause of hyperexcitability, epilepsy, and premature death has remained unresolved. We generated a floxed Scn1a mouse line and used the Cre-Lox method driven by an enhancer from the Dlx 1,2 locus for conditional deletion of Scn1a in forebrain GABAergic neurons. Immunocytochemical studies demonstrated selective loss of Na V 1.1 channels in GABAergic interneurons in cerebral cortex and hippocampus. Mice with this deletion died prematurely following generalized tonic-clonic seizures, and they were equally susceptible to thermal induction of seizures as mice with global deletion of Scn1a . Evidently, loss of Na V 1.1 channels in forebrain GABAergic neurons is both necessary and sufficient to cause epilepsy and premature death in DS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DS occurs from loss of function of SCN1A, which encodes the α-subunit of the voltage-gated sodium channel NaV1.1, prominently expressed in the soma and axon initial segment of neurons (Cheah et al., 2012).”
From Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops (2016) · cites this paper as Cheah et al., 2012
In the citing paper
“In mouse models of Dravets syndrome cortical interneurons cannot sustain high-frequency firing, leading to circuit disinhibition, seizures, and premature death (194, 852).”
From Hippocampal GABAergic Inhibitory Interneurons (2017) · cites this paper as [194]
In the citing paper
“Haploinsufficiency or pathogenic variants of Scn1a cause Dravet Syndrome, a common and intractable form of epileptic encephalopathy characterized by the early onset of seizures17–19.”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [17]
In the citing paper
“As loss of expression of Scn1a is especially associated with PV cIN disfunction15–19”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modification of seizure activity by electrical stimulation: II. Motor seizure
Racine, R. J. (1972) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(72)90177-0 · Cited by 7,141
From Ionic Currents to Molecular Mechanisms
Catterall, W. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)81133-2 · Cited by 2,124
Self-citationDe Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., & De Jonghe, P. (2001) · The American Journal of Human Genetics · doi:10.1086/320609 · Cited by 1,292
Yu, F. H., Mantegazza, M., Westenbroek, R. E., Robbins, C. A., Kalume, F., Burton, K. A., Spain, W. J., McKnight, G. S., Scheuer, T., & Catterall, W. A. (2006) · Nature Neuroscience · doi:10.1038/nn1754 · Cited by 1,173
Self-citationThe origin and specification of cortical interneurons
Wonders, C. P., & Anderson, S. A. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1954 · Cited by 980 · cited 2×
“To target gene expression in GABAergic neurons selectively, we have taken advantage of the Dlx gene family, which encodes homeobox transcription factors that are required for specification, maturation, and survival of forebrain GABAergic neurons (20, 21).”
BackgroundOgiwara, I., Miyamoto, H., Morita, N., Atapour, N., Mazaki, E., Inoue, I., Takeuchi, T., Itohara, S., Yanagawa, Y., Obata, K., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5270-06.2007 · Cited by 879
The core Dravet syndrome phenotype
Dravet, C. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.02994.x · Cited by 630
Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy
Cobos, I., Calcagnotto, M. E., Vilaythong, A. J., Thwin, M. T., Noebels, J. L., Baraban, S. C., & Rubenstein, J. L. R. (2005) · Nature Neuroscience · doi:10.1038/nn1499 · Cited by 502
Self-citationThe VGL-Chanome: A Protein Superfamily Specialized for Electrical Signaling and Ionic Homeostasis
Yu, F. H., & Catterall, W. A. (2004) · Science s STKE · doi:10.1126/stke.2532004re15 · Cited by 488
Self-citationDifferential subcellular localization of the RI and RII Na+ channel subtypes in central neurons
Westenbroek, R. E., Merrick, D., & Catterall, W. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90238-9 · Cited by 477
Self-citation
Research works printed but not linked: 2
- F Kalume, JC Oakley, RE Westenbroek, T Scheuer, WA Catterall, Reduced excitability of GABAergic interneurons in the reticular nucleus of the thalamus and sleep impairment in a mouse model of Severe Myoclonic Epilepsy of Infancy. Soc Neurosci Abs 255, 15 (2010).
- Y Abe, F Kalume, RE Westenbroek, T Scheuer, WA Catterall, Effect of deletion of Nav1.1 channels on sodium current in dissociated neocortical interneurons in a mouse model of severe myoclonic epilepsy in infancy. Soc Neurosci Abs 254, 5 (2010).
Cited by
Sorted by citations
Items 101–200 of 334
Chen, W., Luo, B., Gao, N., Li, H., Wang, H., Li, L., Cui, W., Zhang, L., Sun, D., Liu, F., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci136956 · Cited by 39
Model systems for studying cellular mechanisms of SCN1A -related epilepsy
Schutte, S. S., Schutte, R. J., Barragan, E. V., & O’Dowd, D. K. (2016) · Journal of Neurophysiology · doi:10.1152/jn.00824.2015 · Cited by 39
Fadila, S., Beucher, B., Dopeso‐Reyes, I. G., Mavashov, A., Brusel, M., Anderson, K., Ismeurt, C., Goldberg, E. M., Ricobaraza, A., Hernández-Alcoceba, R., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci159316 · Cited by 38
Therapeutic efficacy of voltage-gated sodium channel inhibitors in epilepsy
Agbo, J., Ibrahim, Z. G., Magaji, S. Y., Mutalub, Y. B., Mshelia, P. P., & Mhya, D. H. (2023) · Acta Epileptologica · doi:10.1186/s42494-023-00127-2 · Cited by 37
Wong, J. C., Makinson, C. D., Lamar, T., Cheng, Q., Wingard, J. C., Terwilliger, E. F., & Escayg, A. (2018) · Scientific Reports · doi:10.1038/s41598-017-17786-0 · Cited by 36
Xie, Y., Ng, N. N., Safrina, O., Ramos, C. M., Ess, K. C., Schwartz, P. H., Smith, M. A., & O’Dowd, D. K. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104627 · Cited by 35
Zhang, L., Tian, J., Lin, Z., & Dong, Z. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c14736 · Cited by 35
Untangling the Dravet Syndrome Seizure Network: The Changing Face of a Rare Genetic Epilepsy
Chopra, R., & Isom, L. L. (2014) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7597-14.2.86 · Cited by 35
Kim, H. W., Quan, Z., Kim, Y., Cheong, E., Kim, H. D., Cho, M., Jang, J., You, Y. R., Lee, J. S., Kim, J. H., et al. (2017) · Brain and Development · doi:10.1016/j.braindev.2017.12.002 · Cited by 34
A selective NaV1.1 activator with potential for treatment of Dravet syndrome epilepsy
Chow, C. Y., Chin, Y. K. ‐., Ma, L., Undheim, E. A. B., Herzig, V., & King, G. F. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113991 · Cited by 36
SCN1A channelopathies: Navigating from genotype to neural circuit dysfunction
Bryson, A., & Petrou, S. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1173460 · Cited by 35
Sudden unexpected death in epilepsy: Respiratory mechanisms
Teran, F. A., Bravo, E., & Richerson, G. B. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-323-91532-8.00012-4 · Cited by 35
Griffith, T. N., Docter, T. A., & Lumpkin, E. A. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2817-18.2019 · Cited by 31
Jansen, N. A., Perez, C., Schenke, M., van Beurden, A. W., Dehghani, A., Voskuyl, R. A., Thijs, R. D., Ullah, G., van den Maagdenberg, A. M. J. M., & Tolner, E. A. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2132-20.2020 · Cited by 33
Voskobiynyk, Y., Battu, G., Felker, S. A., Cochran, J. N., Newton, M. P., Lambert, L. J., Kesterson, R. A., Myers, R., Cooper, G. M., Roberson, E. D., et al. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009195 · Cited by 34
Oláh, V. J., Goettemoeller, A. M., Rayaprolu, S., Dammer, E. B., Seyfried, N. T., Rangaraju, S., Dimidschstein, J., & Rowan, M. J. (2022) · eLife · doi:10.7554/elife.75316 · Cited by 34
GABAergic circuits drive focal seizures
Dossi, E., & Huberfeld, G. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106102 · Cited by 33
Frederiksen, K., Lu, D., Yang, J., Jensen, H. S., Bastlund, J. F., Larsen, P. H., Liu, H., Crestey, F., Dekermendjian, K., Badolo, L., et al. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13626 · Cited by 31
Progressive Worsening of Gait and Motor Abnormalities in Older Adults With Dravet Syndrome
Selvarajah, A., Gorodetsky, C., Marques, P., Ali, Q. Z., Berg, A. T., Fasano, A. A., & Andrade, D. M. (2022) · Neurology · doi:10.1212/wnl.0000000000200341 · Cited by 32
Maheshwari, A., Marks, R. L., Yu, K. M., & Noebels, J. L. (2015) · Epilepsia · doi:10.1111/epi.13265 · Cited by 33
‘Channeling’ therapeutic discovery for epileptic encephalopathy through iPSC technologies
Simkin, D., Ambrosi, C. M., Marshall, K. A., Williams, L. A., Eisenberg, J., Gharib, M., Dempsey, G. T., George, A. L., McManus, O. B., & Kiskinis, E. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.03.001 · Cited by 32
Alshammari, M. A., Khan, M. R., Alasmari, F. F., Alshehri, A. O., Ali, R., Boudjelal, M., Al-Hosaini, K. A., Niazy, A. A., & Alshammari, T. K. (2019) · Neural Plasticity · doi:10.1155/2019/4893103 · Cited by 30
Liu, S., Jin, Z., Zhang, Y., Rong, S., He, W., Sun, K., Wan, D., Huo, J., Xiao, L., Li, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00136 · Cited by 31
Wang, Y.-Y., Zhao, B. T., Wu, M., Zheng, X., Lin, L., & Yin, D. (2021) · Nature Communications · doi:10.1038/s41467-020-20552-y · Cited by 31
The Role of Inhibition in Epileptic Networks
Trevelyan, A. J., Muldoon, S. F., Merricks, E. M., Racca, C., & Staley, K. J. (2015) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0000000000000160 · Cited by 30
From Molecular Circuit Dysfunction to Disease
Dulla, C. G., Coulter, D. A., & Žiburkus, J. (2015) · The Neuroscientist · doi:10.1177/1073858415585108 · Cited by 29
Lupien‐Meilleur, A., Jiang, X., Lachance, M., Taschereau‐Dumouchel, V., Gagnon, L., Vanasse, C., Lacaille, J., & Rossignol, E. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01175-1 · Cited by 27
Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology
Hong, D., & Iakoucheva, L. M. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02356-y · Cited by 32
Emerging drugs for the treatment of Dravet syndrome
Brigo, F., Striano, P., Balagura, G., & Belcastro, V. (2018) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2018.1552937 · Cited by 28
Dravet Syndrome: A Developmental and Epileptic Encephalopathy
Lopez‐Santiago, L. F., & Isom, L. L. (2019) · Epiliepsy currents/Epilepsy currents · doi:10.1177/1535759718822038 · Cited by 28
Cardiac arrhythmias in Dravet syndrome: an observational multicenter study
Shmuely, S., Surges, R., Helling, R. M., Gunning, W. B., Brilstra, E. H., Verhoeven, J. S., Cross, J. H., Sisodiya, S. M., Tan, H. L., Sander, J. W. A. S., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51017 · Cited by 28
Satta, V., Alonso, C., Díez, P., Martín‐Suárez, S., Rubio, M., Encinas, J. M., Fernández‐Ruíz, J., & Sagredo, O. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.602801 · Cited by 28
Low-Level Brain Somatic Mutations Are Implicated in Schizophrenia
Kim, M.-H., Kim, I. B., Lee, J., Cha, D. H., Park, S. M., Kim, J. H., Kim, R., Park, J. S., An, Y., Kim, K., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.01.014 · Cited by 28
Differential distribution of voltage-gated ion channels in cortical neurons
Child, N. D., & Benarroch, E. E. (2014) · Neurology · doi:10.1212/wnl.0000000000000228 · Cited by 29
Derera, I. D., Delisle, B. P., & Smith, B. N. (2017) · eNeuro · doi:10.1523/eneuro.0319-17.2017 · Cited by 28
Excitatory and inhibitory neuron defects in a mouse model of Scn1b‐linked EIEE52
Hull, J. M., O’Malley, H. A., Chen, C., Yuan, Y., Denomme, N., Bouza, A. A., Anumonwo, C., Lopez‐Santiago, L. F., & Isom, L. L. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51205 · Cited by 28
Function of Inhibitory Micronetworks Is Spared by Na+Channel-Acting Anticonvulsant Drugs
Pothmann, L., Müller, C., Averkin, R. G., Bellistri, E., Miklitz, C., Uebachs, M., Remy, S., de la Prida, L. M., & Beck, H. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2395-13.2014 · Cited by 26
The genetics and molecular biology of fever-associated seizures or epilepsy
Deng, H., Zheng, W., & Song, Z. Q. (2018) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2018.2 · Cited by 27
Common Ribs of Inhibitory Synaptic Dysfunction in the Umbrella of Neurodevelopmental Disorders
Rodriguez, R. A., Joya, C., & Hines, R. M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00132 · Cited by 25
Sanchez, R. E. A., Bussi, I. L., Ben‐Hamo, M., Caldart, C. S., Catterall, W. A., & de la Iglesia, H. O. (2019) · SLEEP · doi:10.1093/sleep/zsz173 · Cited by 23
Self-citationHaigh, J., Adhikari, A., Copping, N. A., Stradleigh, T. W., Wade, A. A., Catta-Preta, R., Su-Feher, L., Zdilar, I., Morse, S. J., Fenton, T. A., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00884-0 · Cited by 24
Genetics and gene therapy in Dravet syndrome
Higurashi, N., Broccoli, V., & Hirose, S. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108043 · Cited by 26
Jansen, N. A., Dehghani, A., Breukel, C., Tolner, E. A., & van den Maagdenberg, A. M. J. M. (2020) · Epilepsia · doi:10.1111/epi.16482 · Cited by 22
Yan, W. W., Xia, M. Y., Chiang, J., Levitt, A., Hawkins, N. A., Kearney, J. A., Swanson, G. T., Chetkovich, D. M., & Nobis, W. P. (2021) · eNeuro · doi:10.1523/eneuro.0306-20.2021 · Cited by 24
Massey, C. A., Thompson, S. J., Ostrom, R. W., Drabek, J. M., Sveinsson, O. A., Tomson, T., Haas, E. A., Mena, O. J., Goldman, A. M., & Noebels, J. L. (2021) · Brain Communications · doi:10.1093/braincomms/fcab149 · Cited by 24
Large-scale structural alteration of brain in epileptic children with SCN1A mutation
Lee, Y. J., Yum, M., Kim, M.-J., Shim, W. H., Yoon, H. M., Yoo, I. H., Lee, J., Lim, B. C., Kim, K. J., & Ko, T. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.06.002 · Cited by 24
Are we there yet? A critical evaluation of sudden and unexpected death in epilepsy models
Smith, J., Richerson, G. B., Kouchi, H., Duprat, F., Mantegazza, M., Bezin, L., & Rheims, S. (2023) · Epilepsia · doi:10.1111/epi.17812 · Cited by 23
Scn1a dysfunction alters behavior but not the effect of stress on seizure response
Sawyer, N. T., Helvig, A. W., Makinson, C. D., Decker, M. J., Neigh, G. N., & Escayg, A. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12281 · Cited by 24
Yamakawa, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800109-7.00015-7 · Cited by 23
Scn1b deletion in adult mice results in seizures and SUDEP
O’Malley, H. A., Hull, J. M., Clawson, B. C., Chen, C., Owens‐Fiestan, G., Jameson, M. B., Aton, S. J., Parent, J. M., & Isom, L. L. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.785 · Cited by 23
Sakkaki, S., Barriere, S. J., Bender, A. C., Scott, R. C., & Lenck‐Santini, P. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa101 · Cited by 24
2014 Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression
Galanopoulou, A. S., Wong, M., Binder, D. K., Hartman, A. L., Powell, E. M., Roopra, A., Staba, R. J., Vezzani, A., Fureman, B. E., & Dingledine, R. J. (2016) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-16.3.187 · Cited by 21
Scalise, S., Zannino, C., Lucchino, V., Conte, M. L., Scaramuzzino, L., Cifelli, P., D’Andrea, T., Martinello, K., Fucile, S., Palma, E., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10051075 · Cited by 20
Neonatal and Infantile Epilepsy: Acquired and Genetic ModelsPreprint
Galanopoulou, A. S., & Moshé, S. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022707 · Cited by 22
Gorman, K. M., Peters, C. H., Lynch, B., Jones, L., Bassett, D. S., King, M. D., Ruben, P. C., & Rosch, R. E. (2021) · Brain Communications · doi:10.1093/braincomms/fcab235 · Cited by 22
Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery
del Pozo, A., & Barker‐Haliski, M. L. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114288 · Cited by 22
Takahashi, K., Eultgen, E. M., Wang, S. H., Rensing, N. R., Nelvagal, H. R., Dearborn, J. T., Danos, O., Buss, N. A. P. S., Sands, M. S., Wong, M., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165908 · Cited by 19
Benarroch, E. E. (2013) · Neurology · doi:10.1212/wnl.0b013e31829c002f · Cited by 19
Interneuron Dysfunction in a New Mouse Model of SCN1A GEFS+
Das, A., Zhu, B., Xie, Y., Zeng, L., Pham, A. T., Neumann, J. C., Safrina, O., Benavides, D. R., MacGregor, G. R., Schutte, S. S., et al. (2021) · eNeuro · doi:10.1523/eneuro.0394-20.2021 · Cited by 20
Chuang, S.-H., Westenbroek, R. E., Stella, N., & Catterall, W. A. (2021) · Journal of Experimental Neurology · doi:10.33696/neurol.2.040 · Cited by 17
Self-citationTranscription of the Human Sodium Channel SCN1A Gene Is Repressed by a Scaffolding Protein RACK1
Dong, Z., Tang, L.-J., Deng, G.-F., Zeng, T., Liu, S., Wan, R.-P., Liu, T., Zhao, Q.-H., Yi, Y., Liao, W., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8633-9 · Cited by 21
Progress of Induced Pluripotent Stem Cell Technologies to Understand Genetic Epilepsy
Sterlini, B., Fruscione, F., Baldassari, S., Benfenati, F., Zara, F., & Corradi, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020482 · Cited by 19
Chao, D., Shen, X., & Xia, Y. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/216016 · Cited by 18
Mavashov, A., Brusel, M., Liu, J., Woytowicz, V., Bae, H., Chen, Y.-H., Dani, V. S., Cardenal‐Muñoz, E., Spinosa, V., Aibar, J. Á., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1149391 · Cited by 17
Prioritizing the development of mouse models for childhood brain disorders
Ogden, K. K., Ozkan, E. D., & Rumbaugh, G. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.029 · Cited by 20
Williams, A. D., Kalume, F. K., Westenbroek, R. E., & Catterall, W. A. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.108315 · Cited by 16
Self-citationNestor, M. W., Jacob, S., Sun, B. Q., Prè, D., Sproul, A. A., Hong, S. I., Woodard, C. M., Zimmer, M., Chinchalongporn, V., Arancio, O., et al. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00263.2014 · Cited by 17
Eid, L., Lokmane, L., Raju, P. K., Tadoum, S. B. T., Jiang, X., Toulouse, K., Lupien‐Meilleur, A., Charron-Ligez, F., Toumi, A., Backer, S., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02742-y · Cited by 17
Buss, E. W., Lofaro, O. M., Barnett, A., Leroy, F., Santoro, B., Siegelbaum, S. A., & Bock, T. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2319246121 · Cited by 19
Sahai, N., Bard, A. M., Devinsky, O., & Kalume, F. K. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105154 · Cited by 20
Self-citationLin, G., Lu, P., Zeng, T., Tang, H.-L., Chen, Y., Liu, S., Gao, M., Zhao, Q.-H., Yi, Y., & Long, Y. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.11.002 · Cited by 16
Activity-dependent development of the body’s touch receptors
Santiago, C., Siegrist, J., Africawala, N., Handler, A., Tasnim, A., Anjum, R., Turecek, J., Lehnert, B. P., Renauld, S., Choi, J., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.04.015 · Cited by 19
Neuropathology in the North American sudden unexpected death in epilepsy registry
Leitner, D., Faustin, A., Verducci, C., Friedman, D. J., William, C. M., Devore, S., Wısnıewskı, T., & Devinsky, O. (2021) · Brain Communications · doi:10.1093/braincomms/fcab192 · Cited by 16
Almog, Y., Mavashov, A., Brusel, M., & Rubinstein, M. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.823640 · Cited by 16
Thouta, S., Waldbrook, M., Lin, S., Mahadevan, A., Mezeyova, J., Soriano, M., Versi, P., Goodchild, S. J., & Parrish, R. R. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.964691 · Cited by 15
Rubio, M., Valdeolivas, S., Piscitelli, F., Verde, R., Satta, V., Barroso, E., Montolio, M., Aras, L. M., Marzo, V. D., Sagredo, O., et al. (2016) · Pharmacology Research & Perspectives · doi:10.1002/prp2.220 · Cited by 16
Brain morphometry of Dravet Syndrome
Pérez, A., García‐Pentón, L., Canales-Rodríguez, E. J., Lerma‐Usabiaga, G., Iturria‐Medina, Y., Román, F. J., Davidson, D. J., Alemán‐Gómez, Y., Acha, J., & Carreiras, M. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.06.006 · Cited by 16
Why Are Children With Epileptic Encephalopathies Encephalopathic?
Barry, J. M., & Holmes, G. L. (2016) · Journal of Child Neurology · doi:10.1177/0883073816662140 · Cited by 16
Zayat, V., Kuczynska, Z., Liput, M., Metin, E., Rzońca, S., Smyk, M., Mazurczak, T., Goszczańska‐Ciuchta, A., Leszczyński, P., Hoffman‐Zacharska, D., et al. (2023) · Cells · doi:10.3390/cells12020339 · Cited by 15
Integrative analysis of epilepsy-associated genes reveals expression-phenotype correlations
Chi, W., & Kiskinis, E. (2024) · Scientific Reports · doi:10.1038/s41598-024-53494-2 · Cited by 15
WONOEP appraisal: New genetic approaches to study epilepsy
Rossignol, E., Kobow, K., Simonato, M., Loeb, J. A., Grisar, T. M., Gilby, K. L., Vinet, J., Kadam, S. D., & Becker, A. J. (2014) · Epilepsia · doi:10.1111/epi.12692 · Cited by 16
Uchino, K., Kawano, H., Tanaka, Y., Adaniya, Y., Asahara, A., Deshimaru, M., Kubota, K., Watanabe, T., Katsurabayashi, S., Iwasaki, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90224-4 · Cited by 15
Caplan, R., Mefford, H. C., Berl, M. M., Chang, B. S., Lin, J. J., Mazarati, A. M., Fureman, B. E., & Dingledine, R. J. (2016) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-16.3.182 · Cited by 15
Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy
Hill, S. F., Jafar‐Nejad, P., Rigo, F., & Meisler, M. H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1282201 · Cited by 14
Dyment, D. A., Schock, S., Deloughery, K., Tran, M. H., Ure, K., Nutter, L. M. J., Creighton, A., Yuan, J. S., Banderali, U., Comas, T., et al. (2020) · Genetics · doi:10.1534/genetics.120.303399 · Cited by 14
Chang, B. S., Krishnan, V., Dulla, C. G., Jetté, N., Marsh, E. D., Dacks, P. A., Whittemore, V., & Poduri, A. (2020) · Epiliepsy currents/Epilepsy currents · doi:10.1177/1535759719895280 · Cited by 15
Ricobaraza, A., Buñuales, M., González-Aparicio, M., Fadila, S., Rubinstein, M., Vides-Urrestarazu, I., Banderas, J., Sola-Sevilla, N., Sánchez-Carpintero, R., Lanciego, J. L., et al. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02383-8 · Cited by 14
Xia, D., Zhang, P., Chen, Y., Liu, X., & Chen, Y. (2024) · Seizure · doi:10.1016/j.seizure.2024.02.004 · Cited by 15
Tsien, R. W., & Rosenberg, E. C. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100017 · Cited by 14
Tang, S., Stamberger, H., Calhoun, J. D., Weckhuysen, S., & Carvill, G. L. (2025) · JCI Insight · doi:10.1172/jci.insight.188014 · Cited by 13
Epigenetic landscape and AAV targeting of human neocortical cell classes
Mich, J. K., & Gradinaru, V. (2019) · CaltechAUTHORS (California Institute of Technology) · Cited by 15
Current Pharmacologic Strategies for Treatment of Intractable Epilepsy in Children
Moon, J. U., & Cho, K. (2021) · International Neurourology Journal · doi:10.5213/inj.2142166.083 · Cited by 13
Application of single cell genomics to focal epilepsies: A call to action
Khoshkhoo, S., Lal, D., & Walsh, C. A. (2021) · Brain Pathology · doi:10.1111/bpa.12958 · Cited by 16
Tapia, A., Giachello, C. N., Palomino‐Schätzlein, M., Baines, R., & Galindo, M. I. (2021) · Life · doi:10.3390/life11111261 · Cited by 12
Autonomic dysfunction in epilepsy mouse models with implications for SUDEP research
Bauer, J., Devinsky, O., Rothermel, M., & Koch, H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1040648 · Cited by 13
A novel rat model of Dravet syndrome recapitulates clinical hallmarks
Li, M., Yang, L., Qian, W., Ray, S., Lu, Z., Liu, T., Zou, Y., Naumann, R. K., & Wang, H. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106193 · Cited by 13
AAV-mediated interneuron-specific gene replacement for Dravet syndromePreprint
Mich, J. K., Ryu, J., Wei, A. D., Gore, B. B., Guo, R., Bard, A. M., Martinez, R. A., Bishaw, Y. M., Luber, E. M., Oliveira, L. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.15.571820 · Cited by 12
Self-citationRichards, K., Jancovski, N., Hanssen, E. G., Connelly, A., & Petrou, S. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147157 · Cited by 9
Kumagai, S., Nakajima, T., & Muramatsu, S. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2386339 · Cited by 11
Early developmental alterations of CA1 pyramidal cells in Dravet syndrome
Jones, S. P., O’Neill, N., Carpenter, J. C., Muggeo, S., Colasante, G., Kullmann, D. M., & Lignani, G. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106688 · Cited by 16
Metadata
- Authors
- Cheah, C. S., Yu, F. H., Westenbroek, R. E., Kalume, F. K., Oakley, J. C., Potter, G. B., Rubenstein, J. L., & Catterall, W. A.
- Affiliations
- Department of Pharmacology and
- Seoul National University (KR)
- University of Washington (US)
- University of California, San Francisco (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-08-20
- Volume
- 109
- Issue
- 36
- Pages
- 14646-14651
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3437823
- OpenAlex
- W2159213224
- Cited by
- 336
- References
- 28
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 32 · 2023: 26 · 2022: 23 · 2021: 42 · 2020: 21 · 2019: 28 · 2018: 16 · 2017: 19 · 2016: 24 · 2015: 20 · 2014: 21 · 2013: 23 · 2012: 1
- FWCI
- 14.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- McKnight Foundation
- National Research Foundation
- National Research Foundation of Korea
- National Institutes of Health (MH049428)
- National Institute of Mental Health (R37MH049428)
- National Institute of Neurological Disorders and Stroke (R01NS025704)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Dravet syndrome, Nav1.1 sodium channel, SCN1A, GABAergic interneurons, conditional knockout, epilepsy, premature mortality, seizures, hippocampus, cerebral cortex, tonic-clonic seizures
- MeSH terms
- Animals, Electrocardiography, Electroencephalography, Epilepsies, Myoclonic, Hippocampus, Immunohistochemistry, Interneurons, Mice, Transgenic, Mutation, Plasmids, Prosencephalon, Mice, NAV1.1 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review